Kucherlapati, Melanie H <br/><br/>
Genotype directed therapy in murine mismatch repair deficient tumors.  [electronic resource] 

 -  PloS one  2013 
 - e68817 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0068817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>DNA Mismatch Repair--genetics<br/>Disease Models, Animal<br/>Disease Progression<br/>Gene Rearrangement--drug effects<br/>Genotype<br/>Humans<br/>Imidazoles--pharmacology<br/>Integrases--metabolism<br/>Intestinal Neoplasms--drug therapy<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>MutS Homolog 2 Protein--deficiency<br/>Neoplasm Proteins--metabolism<br/>Neoplasms--enzymology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Positron-Emission Tomography<br/>Quinolines--pharmacology<br/>TOR Serine-Threonine Kinases--metabolism<br/>Up-Regulation--drug effects<br/>Wnt Proteins--metabolism